Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 5Completed 4Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other 1

Conditions

Endometrial Neoplasms 2Turcot syndrome 1Overweight 1Obesity 1Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Endometrioid 1

Interventions

Paclitaxel 8Carboplatin 7Tirzepatide 3Observation 3Cisplatin 3pembrolizumab 2dostarlimab 2Megestrol Acetate 2Medroxyprogesterone Acetate 2Blood Specimen Collection 2trilaciclib 1toripalimab 1tislelizumab 1sintilimab 1semaglutide 1olaparib 1montelukast 1inavolisib 1enfortumab vedotin 1ceralasertib 1camrelizumab 1apatinib 1anlotinib 1Watchful Waiting 1Vaginal Smears 1Topotecan 1Tablets 1Specimen Handling 1Sensitivity Training Groups 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Endometrial Neoplasms × Medroxyprogesterone Acetate × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Peking University People's Hospital

Phase NA Not yet recruiting
10 enrolled
Gynecologic

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡